The c.43_44insCTG Variation in PCSK9 Is Associated With Low Plasma LDL-Cholesterol in a Caucasian Population

    loading  Checking for direct PDF access through Ovid

Abstract

The genetic etiology of familial hypobetalipoproteinemia (FHBL) is unclear in the majority of cases. Mutations in apolipoprotein B (APOB) are the only confirmed causes of FHBL. Recently, loss-of-function mutations ofPCSK9gene have been shown to be associated with the hypocholesterolemia phenotype. Our primary goal was to confirm that mutations inPCSK9could be another cause of FHBL. Using the sequencing approach, we found that the c.43_44insCTG variation inPCSK9, a common in-frame insertion in both African American and Caucasian populations, is associated with the hypocholesterolemia phenotype in three FHBL families. Then we tested whether this variation could be associated with lower cholesterol levels in the general population. A total of 403 subjects from a Caucasian population, in which hypobetalipoprotein (HBL) and normal groups were classified using standard criteria, were sequenced for this variation. The allele frequency of this variation in the HBL group was 0.186, but was only 0.128 in the normal lipid group. The mean plasma low-density lipoprotein (LDL)-cholesterol level in subjects heterozygous for this variant is significantly lower than that in the normal group (p<0.01). Heterozygous subjects also had higher high-density lipoprotein (HDL)-cholesterol levels (p<0.01). In general, LDL-cholesterol concentration in individuals withPCSK9c.43_44insCTG variation was ∽10-15 mg/dL lower than that in normal individuals. We conclude that the c.43_44insCTG variant plays a role in lowering cholesterol in the general population. Hum Mutat 27(5), 460-466, 2006. Published 2006 Wiley-Liss, Inc.†

Related Topics

    loading  Loading Related Articles